Neuland Laboratories DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.74×	0.74×	0.75×	0.75×	0.76×
	1.01×	1.01×	1.34×	1.00×	0.98×
	28.0%	23.9%	17.5%	25.8%	18.4%
	0.79×	0.79×	0.74×	0.91×	0.80×
	1.56×	1.56×	1.43×	1.43×	1.59×
	25.9%	22.2%	18.6%	25.0%	17.5%
	21.4%	21.4%	18.5%	26.4%	17.8%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NEULANDLAB₹19,970.00

Neuland Laboratories Ltd.

· Pharma & Health

₹ CrorePeersDIVISLAB LAURUSLABS NH NATCOPHARM LALPATHLAB SAILIFE COHANCE ASTERDMMcap ₹25,762 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.76	0.75	0.75	0.74	0.74
Interest Burden (Pretax/EBIT) ×	0.98	1.00	1.34	1.01	1.01
EBIT Margin %	18.39	25.85	17.45	23.86	28.03
Asset Turnover ×	0.80	0.91	0.74	0.79	0.79
Financial Leverage (Assets/Equity) ×	1.59	1.43	1.43	1.56	1.56
ROE (5-step product, year-end total equity) %	17.45	25.03	18.63	22.22	25.92
ROE (owners' profit / average owners' equity) %	17.83	26.36	18.53	21.42	21.42

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.